Do bisphosphonates and RANKL inhibitors alter the progression of coronary artery calcification? A systematic review and meta-analysis protocol

INTRODUCTION: Whether bisphosphonates and RANKL inhibitors play a novel role in delaying cardiovascular calcification is unknown. Their action on regulatory enzymes in the mevalonic acid pathway, which is implicated in both bone and lipid metabolism, may be a novel therapeutic target to manage coron...

Descripción completa

Detalles Bibliográficos
Autores principales: Saunders, Samantha Louise, Chaudhri, Kanika, McOrist, Nathan Scott, Gnanenthiran, Sonali R, Shalaby, Grant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558804/
https://www.ncbi.nlm.nih.gov/pubmed/36207048
http://dx.doi.org/10.1136/bmjopen-2022-066255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558804/
https://www.ncbi.nlm.nih.gov/pubmed/36207048
http://dx.doi.org/10.1136/bmjopen-2022-066255

Ejemplares similares